Significant Ownership of Adimab, LLC

Signature - Title
/s/ Philip Chase - Philip Chase, Chief Executive Officer
Location
Lebanon, NH
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Adimab, LLC.

Notify me when Adimab, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Adimab, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
IVVD Invivyd, Inc. Common Stock, $0.0001 par value per share 7.3% $47,210,856 -$448,106 20,262,170 -0.94% Adimab, LLC 23 Dec 2025

Schedules 13D/G Reported by Adimab, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.